China Approves World’s First Invasive Brain-Computer Interface Chip

Chinese regulators have approved the world’s first invasive brain-computer interface (BCI) for use beyond clinical trials. The NEO device, created by startup Neuracle Technology in partnership with researchers from Tsinghua University, is designed for patients with limb paralysis caused by spinal cord injuries.

The coin-sized chip is implanted beneath the skull and secured to the dura mater. Sensors read brain signals, which are then transmitted to an external computer for conversion into commands. During rehabilitation, patients use a robotic glove to relearn hand movements. One of the first trial participants, Dong, was able to grasp an object independently by the ninth day of training.

According to China’s National Medical Products Administration, NEO is suitable for patients aged 18 to 60 with residual hand function. The implantation procedure takes approximately 90 minutes, with rehabilitation beginning one week post-surgery. The technology holds potential to expand capabilities for individuals with limited mobility, enabling them to perform daily tasks.

Experts highlight that NEO’s approval marks a significant milestone in neurotechnology. Unlike non-invasive solutions, invasive BCIs provide more precise signal reading, unlocking new possibilities for medical and research applications.